Stellantis Unveils 70 Billion DecadeLong Strategy Commits to 60 New Models Chinas Worst Mining Disaster in Over a Decade Claims 82 Lives at Liushenyu Mine Implications for Coal Sector Safety Hot Inflation Data Pushes Rate Cut Expectations Off the Table Through 2027 Shopians Political Turnout Signals Potential Shift in Kashmirs Investment Climate Jardine Matheson Acquires Australian Imaging Firm IMED in 31 Billion Deal Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks CEPU Q4 2024 Earnings Steep Loss Shocks Market as Adjusted Earnings Miss by Over 164 DTI Q1 2026 Earnings EPS Misses Estimates Revenue Data Unreported Stock Declines TWAV Q3 2022 Earnings Deep Earnings Miss Amid Ongoing Development Phase RILYT Q1 2024 Earnings Negative EPS Highlights Challenges for Senior Notes Holders Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Reported as Stock Moves Lower RRR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 377 Opera OPRA Rallies 166 as Shares Test Key Resistance Near 1861 B2Gold Corp BTG Gains Momentum With 354 Rally as Gold Sentiment Brightens RTX Corporation RTX Edges Higher Approaches Key Resistance Level Satellos Bioscience MSLE Surges 7 as Biotech Stock Breaks Above Key Support Adobe Inc ADBE Sees Mild Decline Amid Consolidation Near Key Levels Rezolve AI Warrants RZLVW Edge Higher Amid Low Volume Key Levels to Watch Newbury Street II Acquisition Corp Warrant NTWOW Holds Steady at 018 Amid Tight Trading Range PT Telekomunikasi Indonesia TLK Slides 472 as Broader Market Headwinds Weigh on Telecom Sector Teekay Corporation TK Retreats from Resistance Approaches Key Support Zone BioLineRx BLRX Surges Over 9 Biotech Stock Breaks Above Key Support Level US Consumer Prices Rise 38 in April Exceeding Expectations and Marking Highest Since May 2023 StoneX Group Inc SNEX Q1 2026 Earnings EPS Surges Past Estimates with 365 Beat Kolibri Global Energy KGEI Gains Over 35 as It Approaches Key Resistance Level Reading International Inc RDIB Q3 2025 Earnings EPS Misses Estimates as Operating Challenges Persist JBS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Market Conditions IRTC Q1 2026 Earnings EPS Beat by 47 Amid Ongoing Revenue Uncertainty DPRO Q1 2026 Earnings WiderthanExpected Loss No Revenue Reported Stock Gains 288 Amicus Therapeutics FOLD Q4 2025 Earnings EPS Falls Far Short of Estimates Amid Thin Operational Detail XLO Q1 2026 Earnings Narrower Loss and Positive Stock Reaction Signal Progress CPS Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cost Pressures